B

BGBx

Healthcare consultancy translating science into stories

Group Copy Supervisor - Market Access & Payer

Full-Time
$125k - $150k
Senior
Bachelor's, Master's
Remote in USA
Remote
Content & WritingCopywriting & Creative Writing

About the job

Requirements
  • At least 6 years of experience in healthcare or pharmaceutical copywriting.
  • Strong understanding of medical, scientific, and economic concepts, including translating complex data into compelling content for payer and access audiences.
  • Strong understanding of regulatory requirements, including FDA, OPDP, and medical/legal review processes, as well as market access considerations such as HEOR, value messaging, and reimbursement.
  • Proficiency in Microsoft Office and familiarity with content management and collaboration tools.
Responsibilities
  • Lead development of access-focused scientific and promotional content, ensuring alignment with brand strategy, value proposition, and compliance requirements.
  • Oversee and mentor junior copywriters, providing guidance, feedback, and career development support.
  • Partner with creative, medical, market access, and account teams to develop content across digital, print, video, sales materials, payer tools, and other channels.
  • Review and edit content for scientific accuracy, clarity, engagement, and adherence to brand voice, with a focus on effectively communicating clinical and economic outcomes.
  • Use industry trends, including payer landscape, reimbursement dynamics, access considerations, regulatory guidelines, and competitive insights, to inform copy and content.
  • Present content to internal teams and clients, explain strategic rationale, and address feedback.
  • Manage workload and workflow to ensure timely delivery of high-quality materials.
  • Collaborate with medical, legal, and regulatory teams to navigate approval processes efficiently.
Desired Qualifications
  • Experience working across a variety of therapeutic areas.
  • Managerial experience.

About the company

BGBx is a healthcare consultancy that helps pharmaceutical, biotech, and medical device companies turn scientific advances into practical, credible brand stories and strategies. Its services include medical communications to explain science clearly, market access planning to help products reach patients, and payer strategy to work with insurance decision-makers. The work is done by a team that combines clinical knowledge, academic insight, and industry experience, and is delivered through project-based engagements that aim for real-time, real-world impact. Unlike firms that rely on generic marketing, BGBx differentiates itself with a strong, multidisciplinary medical team and a clear focus on translating science into strategies that improve access and outcomes. The company’s goal is to help clients communicate complex science effectively while shaping reimbursement and market access to bring new therapies and devices to patients more efficiently.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2014

Get referred to BGBx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 BGBx rebrand signals broader commercial scope and stronger cross-sell opportunities.
  • Greenhouse listed 17 open roles in September 2026, showing active hiring.
  • The 2023 Kx Advisors acquisition expanded strategy consulting across biopharma and medical devices.

What critics are saying

  • BGBx still depends on pharma marketing budgets and consulting project flow.
  • Rebranding from BGB Group to BGBx risks client confusion and internal execution drag.
  • If Kx Advisors or Hayden integration stalls, competitors poach strategic accounts quickly.

What makes BGBx unique

  • June 2026 BGBx unified consulting, communications, science, data, and technology under one brand.
  • Kx Advisors and Hayden Consulting Group deepen market access and lifecycle strategy breadth.
  • BGBx claims 3D science, integrating medical, data, and behavioral science for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

5%
GlobeNewswire
Jan 7th, 2026
BGB Group acquires Hayden Consulting Group to expand market access expertise

BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.

Citybiz
Nov 19th, 2024
BGB Group Appoints David Coman as Chief Executive Officer

BGB Group appoints David Coman as Chief Executive Officer.

MM+M
Jun 21st, 2024
BGB Group's new creative chief Chris Palmer on AI's growth potential

BGB Group recently hired Chris Palmer as its new chief creative officer, who joined from Havas Life New York.

O'Dwyer's PR
Feb 28th, 2024
On the Move: APCO's Camarco Unit Names Cohen Tech Leader

Kuzel comes to imre from BGB Group, where she was EVP data, analytics and customer experience.

Business Wire
Feb 1st, 2024
Bgb Group Announces Partnership With Scrum50 To Deliver High-Impact, Consumer-Centric Creative To Healthcare Clients

NEW YORK--(BUSINESS WIRE)--BGB Group (BGB), an award-winning healthcare commercialization and communications company headquartered in New York City with offices in Washington DC, Boston, and London, today announced a strategic partnership with Scrum50 (S50), a dynamic, agile-first creative agency based in South Norwalk, CT. This collaboration marks a transformative alliance, the next phase of BGB’s expertise enhancement aimed at remaining ahead of biopharma’s biggest challenges. The teams are set to redefine creativity and impact in the healthcare sector. S50 will continue to operate independently across all industry sectors. “We are excited to formalize our partnership with S50,” noted Greg Passaretti, Founding Partner of BGB Group. “We’ve been working together for nearly a year, and we realized that there’s much more that we can accomplish for a marketplace in need of broader creative and engagement solutions.”